Adenomas Are Frequent in PMS2 Lynch Syndrome patients but Rarely Mismatch Repair Deficient
Andini, K. D.; Lanjouw, L.; Suerink, M.; Terlouw, D.; Ahadova, A.; Aretz, S.; Bigirwamungu-Bargeman, M.; Blaeker, H.; de Vos Tot Nederveen Cappel, W. H.; Endris, V.; Holinski-Feder, E.; Jacobs, M. A. J. M.; Koornstra, J. J.; Langers, A. M. J.; Loeffler, M.; Lepisto, A.; Mecklin, J.-P.; Kloor, M.; Moeslein, G.; Peltomaki, P.; Pylvanainen, K.; Redler, S.; Renkonen-Sinisalo, L.; Seppala, T. T.; Strassburg, C. P.; Steinke-Lange, V.; Morak, M.; Tops, C. M. J.; van de Meeberg, P. C.; van Kouwen, M.; Vangala, D. B.; Katerberg, B.; Verhulst, M.-L.; von Knebel Doeberitz, M.; Huneburg, R.; Zachariae, S.
Show abstract
BackgroundLynch syndrome (LS) predisposes carriers to the accelerated development of colorectal cancer (CRC). Pathogenic PMS2 variant (PV) carriers are believed to have the lowest CRC risk and develop MMR deficiency (dMMR) at a later stage of CRC progression. In addition, the PMS2 adenoma incidence rate is considered lowest among all MMR PV carriers. However, neither the exact adenoma incidence nor the prevalence of dMMR among PMS2 PV carriers is known. MethodWe established a cohort of 171 confirmed PMS2 PV carriers in the Netherlands and collected clinical excerpts to establish adenoma incidence. We also collected 123 paraffin blocks from PMS2 PV carriers and investigated PMS2 and MLH1 expression with immunohistochemistry (IHC). ResultsWe collected 123 paraffin blocks containing adenomatous lesions from PMS2 PV carriers removed who underwent surveillance colonoscopy between 2018-2023. Of the 123 IHC-stained lesions 109 were tubular adenomas, 86.2% of which (n=94/109) retained PMS2 protein expression. All specimens showed intact MLH1 staining. ConclusionAdenomas are frequent in PMS2 PV carriers, although the majority of PMS2-associated adenomas retained MMR-proficiency. The result of our study corroborates the late involvement of PMS2 deficiency in the evolution of to PMS2 associated CRC.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multi-centre derivation and validation of a colitis-associated colorectal cancer risk prediction web-tool 93%
- Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitis 92%
- Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2 91%
Similar papers in this journal
Similar papers in this journal
- Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank 95%
- A systems approach to enhance Lynch syndrome diagnosis through tumor testing 90%
- Functional annotation with expression validation identifies novel metastasis-relevant genes from post-GWAS risk loci in sporadic colorectal carcinomas 89%
Similar papers in this journal
- APC Mutation marks an aggressive subtype of BRAF mutant colorectal cancers 94%
- DNA mismatch repair gene variant classification: evaluating the utility of somatic mutations and mismatch repair deficient colonic crypts and endometrial glands 93%
- Deep sequencing of early T stage colorectal cancers reveals disruption of homologous recombination repair in microsatellite stable tumours with high mutational burdens 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.